GMP Cell Banking Services Market Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

                                                                               
The concept of cell banking arose as a result of the burgeoning pharmaceutical industry's struggle to find treatments and cures for various chronic and other ailments.

       GMP Cell Banking Services Market


The concept of cell banking arose as a result of the burgeoning pharmaceutical industry's struggle to find treatments and cures for various chronic and other ailments. Due to limited storage capacity for cells needed for research in the fields of regenerative medicine, somatic cell therapy, gene therapy, and tissue-engineered products, they are increasingly outsourcing it to other entities specialising in it. GMP is an abbreviation for "Good Manufacturing Practice." According to a recent report on GMP cell banking services, the market is expected to grow in the near term due to capacity constraints faced by pharmaceutical manufacturing companies and medical research institutes.

Increased funding for research and development in rare diseases is expected to drive growth in the global GMP cell banking services market during the forecast period. For example, the Food and Drug Administration (FDA) in the United States funds rare disease research through congressionally mandated programmes such as the Orphan Products Grants Program, which supports natural history studies and clinical trials for rare diseases. Furthermore, the establishment of stem cell banking resource centres is expected to aid in market growth. For example, Stemlife Berhad, a Malaysian cord blood bank, will open a Stem Cell Banking Resource Center in Brunei's Jerudong Park Medical Center in March 2020.


Market Segmentation:

By Cell Type
  • Mammalian
  • Microbial
  • Insect
  • Yeast
  • Avian
  • Stem Cell
  • Others

By End User
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations

The major players operating in the global GMP cell banking services market include, WuXi AppTec Group, Charles River Laboratories International, Inc., Eurofins Scientific, Merck KGaA, Lonza Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova, Goodwin Biotechnology Inc., and Paragon Bioservices, Inc.

Comments

Post a Comment

Popular posts from this blog

Flavors and Fragrances Market: A Comprehensive Analysis of Current Trends and Future Outlook

Image
  Flavors and Fragrances Market Introduction: The global flavors and fragrances market has witnessed remarkable growth in recent years, driven by increasing consumer preferences for enhanced sensory experiences in various industries. Flavors and fragrances play a vital role in food and beverages, personal care products, household products, and the pharmaceutical industry. This report provides an in-depth analysis of the flavors and fragrances market, highlighting key trends, market dynamics, and future prospects. Market Overview: The flavors and fragrances market has experienced substantial growth, with a projected CAGR of X% from 2023 to 2028. The market is primarily driven by rising disposable incomes, urbanization, and changing consumer lifestyles. Key market players are continually investing in research and development activities to introduce innovative flavors and fragrances that cater to evolving consumer demands. Segmentation and Key Market Players: The market can...
Read more

Exploring the Different Types of Blood Clotting Factors and Their Functions

Image
  Blood Clotting Factor Coagulation, another name for blood clotting, is a complicated process that is essential for reducing excessive bleeding after an injury. It entails a chain of events that cause a blood clot to develop, sealing the injured blood artery and stopping further bleeding. Blood clotting factors are a group of proteins that control these processes. Roman numerals from I to XIII are used to identify each of the 13 distinct blood clotting factors. The liver makes them, and platelets, the tiny blood cells that aid in blood clotting, also make some of them. Each of these elements interacts with the others in a series of reactions, activating the one before it. Factor I : Also known as fibrinogen, is a protein that is converted into fibrin, the main component of a blood clot. Factor II, also known as prothrombin, is converted into thrombin, which converts fibrinogen into fibrin. Factor III, also known as tissue factor, is released by damaged tissue and initiates the...
Read more

Global Orthopedic Imaging Market Size By Product, By Indication, By End User, Analysis And Forecast 2027

Image
                              Orthopedic Imaging Market Medical imaging in orthopaedics allows doctors to examine the interior architecture of the body non-invasively to aid in the diagnosis of a medical disease. Medical imaging technologies detect and track illnesses and injuries by providing pictures that represent the interior anatomical features of the patient's body. These gadgets are utilised as a knowledge tool to assist clinicians in determining the condition and its response to therapy. Orthopedic medical imaging provides clinicians with dependable, accessible, and high-quality imaging, which is an important criterion for medical decision-making and may lessen the need for surgical operations. Increased incidences of bone fracture trauma due to falls, motor vehicle accidents, or sports injuries necessitate prompt medical attention, which orthopaedic medical imaging systems may deliver. According to the ...
Read more